Ethyl 2-(trifluoromethylsulfonyloxy)-1-cyclohexene-1-carboxylate, 95.0%, 25g

7,12-DIHYDRO-9-NITROINDOLO[3,2-D][1]BENZAZEPIN-6(5H)-ONE, 95%, 5mg

2-(3-methylphenyl)-1,3-dioxoisoindoline-5-carboxylic acid, 95.0%, 500mg

4-(2-(Dimethylamino)ethyl)aniline, 95.0%, 5g

(S)-N-Boc-Azetidine-2-carboxylic acid methyl ester, 97.0%, 10g

2'-Methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-carboxylic acid, 98%, 1g

6-Bromoimidazo[1,2-a]pyrazine, 97.0%, 100g

Methyl 5-fluorobenzofuran-2-carboxylate, 95%, 1g

4-Bromo-5-chloro-1H-indazole, 95.0%, 5g

4-(2-FLUOROPHENYL)-1H-PYRAZOL-5-AMINE, 95.0%, 250mg

4-Fluorobenzo[b]thiophene, 95.0%, 1g

Colonne capillaire GC ROTI®Cap-1701 MS, 30 m, 0,25 mm, 0,25 µm, 1 pièce(s)

3H-Cyclopenta[c]quinoline, 4-(6-bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-, (3aS,4R,9bR)-, 99%, 250mg